申请人:Array Biopharma, Inc.
公开号:EP2826774A1
公开(公告)日:2015-01-21
Compounds of Formula (IV, VI): in which A1, A2, P2, P3, R7a, R7b, R8, R9, R10 and Z2 have the meanings given in the specification, are compounds useful for the preparation of DP2 receptor modulators useful in the treatment of immunologic diseases.
式(IV、VI)化合物:其中 A1、A2、P2、P3、R7a、R7b、R8、R9、R10 和 Z2 具有说明书中给出的含义,是用于制备治疗免疫性疾病的 DP2 受体调节剂的化合物。